• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.

作者信息

Hanhart Joel, Vinker Shlomo

机构信息

Jerusalem, Israel.

Tel Aviv, Israel.

出版信息

Am J Ophthalmol. 2016 Jun;166:204-205. doi: 10.1016/j.ajo.2016.03.027. Epub 2016 Apr 11.

DOI:10.1016/j.ajo.2016.03.027
PMID:27079300
Abstract
摘要

相似文献

1
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.年龄相关性黄斑变性患者单次或重复玻璃体内注射贝伐单抗后发生心肌梗死和中风的风险
Am J Ophthalmol. 2016 Jun;166:204-205. doi: 10.1016/j.ajo.2016.03.027. Epub 2016 Apr 11.
2
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.
Am J Ophthalmol. 2016 Jun;166:205. doi: 10.1016/j.ajo.2016.03.026. Epub 2016 Apr 16.
3
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.年龄相关性黄斑变性患者单剂量或重复剂量玻璃体内注射贝伐单抗后发生心肌梗死和中风的风险
Am J Ophthalmol. 2016 Mar;163:53-58. doi: 10.1016/j.ajo.2015.11.030. Epub 2015 Dec 15.
4
Incidence of myocardial infarction, stroke, and death in patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor therapy.玻璃体内抗血管内皮生长因子治疗的年龄相关性黄斑变性患者中心肌梗死、中风和死亡的发生率
Am J Ophthalmol. 2015 Mar;159(3):557-64.e1. doi: 10.1016/j.ajo.2014.12.005. Epub 2014 Dec 10.
5
Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.玻璃体内抗血管内皮生长因子单克隆抗体相关的心血管事件和出血风险：系统评价与荟萃分析
JAMA Ophthalmol. 2014 Nov;132(11):1317-26. doi: 10.1001/jamaophthalmol.2014.2333.
6
High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.高剂量玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性难治性色素上皮脱离
Korean J Ophthalmol. 2016 Aug;30(4):265-71. doi: 10.3341/kjo.2016.30.4.265. Epub 2016 Jul 21.
7
Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis.血管内皮生长因子抑制剂治疗黄斑变性后的卒中发生率：时间序列分析。
Ophthalmology. 2012 Aug;119(8):1604-8. doi: 10.1016/j.ophtha.2012.05.028. Epub 2012 Jun 19.
8
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?年龄相关性黄斑变性患者玻璃体内注射抗血管内皮生长因子药物治疗会出现快速耐受性吗？
Ophthalmology. 2008 Dec;115(12):2199-205. doi: 10.1016/j.ophtha.2008.07.007. Epub 2008 Oct 18.
9
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.与年龄相关性黄斑变性治疗相关的死亡、心肌梗死、出血和中风风险。
Arch Ophthalmol. 2010 Oct;128(10):1273-9. doi: 10.1001/archophthalmol.2010.223.
10
Does intravitreal injections of bevacizumab for age-related macular degeneration affect long-term intraocular pressure?抗血管内皮生长因子药物玻璃体腔内注射治疗年龄相关性黄斑变性是否会影响长期眼压？
J Glaucoma. 2014 Sep;23(7):446-8. doi: 10.1097/IJG.0b013e3182946505.

引用本文的文献

1
Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis.年龄相关性黄斑变性患者急性心肌梗死后玻璃体内注射贝伐单抗相关的死亡率：一项基于人群的回顾性生存分析。
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):651-663. doi: 10.1007/s00417-018-3917-9. Epub 2018 Feb 10.